This trial is a prospective, multi-center, 1:1 randomized using paclitaxel coated balloon versus stent to treat intracranial stenosis of 70-99% degree. And primary endpoint is angiographic restenosis at 6 months post-procedure.
The purpose of the RCT trial is to determine whether DCB is not inferior to stent in treating intracranial de novo stenosis.